RICHARD JAMESON: Open Payments
NPI 1124059589 · MINEOLA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,578 in 70 payments from 12 companies in 2025. Trend: 2023 $1,842 · 2024 $1,966 · 2025 $1,578
Food & beverage: $1,578
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $312 |
| ABBVIE INC. | 9 | $229 |
| Novo Nordisk Inc | 8 | $226 |
| GlaxoSmithKline, LLC. | 11 | $205 |
| PFIZER INC. | 9 | $187 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $136 |
| Exact Sciences Corporation | 5 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $63 |
| Lilly USA, LLC | 4 | $62 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
Products named: TRELEGY ELLIPTA, BREZTRI, Ozempic, ELIQUIS, Kerendia, AIRSUPRA, LINZESS, JARDIANCE.
Industry payments across TX — which companies pay providers there.
